IL6 and cervical cancer: Pretreatment with TMS-TMF-4f reduced the green fluorescence intensity (IL-6-induced STAT3 phosphorylation) and p-STAT protein levels in both HeLa and CaSki cervical cancer cells (Figure 4a,b).